Bez kategorii

Immunotherapy and new onset refractory status epilepticus

We are pleased to share information regarding newly published review article on the role of immunotherapy in managing new onset refractory status epilepticus. The article, titled “Second-line Immunotherapy in New Onset Refractory Status Epilepticus” by Aurélie Hanin, Eyal Muscal, Lawrence J. Hirsch, was released on March 2 in the journal Epilepsia. This publication comes highly recommended by the ILAE for its insightful contributions to the field.